19.95
price up icon7.23%   1.34
after-market After Hours: 19.85 -0.10 -0.50%
loading
Summit Therapeutics Inc stock is traded at $19.95, with a volume of 2.31M. It is up +7.23% in the last 24 hours and down -12.09% over the past month. Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
See More
Previous Close:
$18.61
Open:
$18.5
24h Volume:
2.31M
Relative Volume:
0.48
Market Cap:
$14.30B
Revenue:
$956.00K
Net Income/Loss:
$-116.03M
P/E Ratio:
-11.87
EPS:
-1.6811
Net Cash Flow:
$-93.84M
1W Performance:
+4.53%
1M Performance:
-12.09%
6M Performance:
+395.16%
1Y Performance:
+1,021%
1-Day Range:
Value
$18.27
$19.98
1-Week Range:
Value
$18.27
$20.18
52-Week Range:
Value
$1.64
$33.89

Summit Therapeutics Inc Stock (SMMT) Company Profile

Name
Name
Summit Therapeutics Inc
Name
Phone
650-460-8308
Name
Address
2882 SAND HILL ROAD, MENLO PARK
Name
Employee
105
Name
Twitter
@summitplc
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
SMMT's Discussions on Twitter

Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-28-18 Downgrade Janney Buy → Neutral
May-02-18 Initiated Janney Buy
Apr-12-18 Reiterated Needham Buy
Feb-13-18 Initiated BTIG Research Buy
Jan-04-18 Initiated SunTrust Buy
Dec-01-17 Resumed H.C. Wainwright Buy
Nov-16-16 Reiterated RBC Capital Mkts Outperform
Oct-05-16 Reiterated Needham Buy
Sep-16-16 Initiated H.C. Wainwright Buy
Mar-30-15 Initiated Needham Buy
Mar-30-15 Initiated Oppenheimer Outperform
View All

Summit Therapeutics Inc Stock (SMMT) Latest News

pulisher
03:40 AM

The Manufacturers Life Insurance Company Raises Stake in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

03:40 AM
pulisher
Oct 10, 2024

Summit Therapeutics (NASDAQ:SMMT) Trading Down 1.2%Here's What Happened - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Summit Therapeutics Inc (SMMT) Q2 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance UK

Oct 09, 2024
pulisher
Oct 09, 2024

Summit Therapeutics Inc (SMMT) Q2 2024 Earnings Call Highlights: Strategic Advances and Financial Insights - GuruFocus.com

Oct 09, 2024
pulisher
Oct 09, 2024

Summit Therapeutics (NASDAQ:SMMT) Stock Price Down 1%Time to Sell? - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

Squarepoint Ops LLC Acquires 56,614 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Summit Therapeutics (NASDAQ:SMMT) Shares Up 3.7%Still a Buy? - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Summit Therapeutics (NASDAQ:SMMT) Shares Down 1.5%What's Next? - MarketBeat

Oct 07, 2024
pulisher
Oct 07, 2024

2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts - Yahoo Finance

Oct 07, 2024
pulisher
Oct 07, 2024

Millennium Management LLC Takes Position in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Summit Therapeutics Inc. (SMMT): Hedge Funds Are Bullish On This NASDAQ Stock Right Now - MSN

Oct 06, 2024
pulisher
Oct 06, 2024

Summit Therapeutics Inc. (SMMT): Hedge Funds Are Bullish On This NASDAQ Stock Right Now - Insider Monkey

Oct 06, 2024
pulisher
Oct 06, 2024

Summit Therapeutics Inc. (SMMT): Hedge Funds Are Bullish On This NASDAQ Stock Right Now - Yahoo Finance

Oct 06, 2024
pulisher
Oct 05, 2024

Summit Therapeutics falls after late-stage data for lead asset - MSN

Oct 05, 2024
pulisher
Oct 05, 2024

Is Summit Therapeutics a Millionaire Maker? - Yahoo Finance

Oct 05, 2024
pulisher
Oct 05, 2024

(SMMT) Trading Report - Stock Traders Daily

Oct 05, 2024
pulisher
Oct 05, 2024

U.S. Dollar Index (DXY) QuotePress Release - The Globe and Mail

Oct 05, 2024
pulisher
Oct 04, 2024

Bay Area surfer, Scientologist and billionaire is tackling one of medicine’s toughest problems - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Oct 04, 2024
pulisher
Oct 04, 2024

Summit Therapeutics (NASDAQ:SMMT) Trading Up 0.3%Still a Buy? - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market (SMMT) - Seeking Alpha

Oct 04, 2024
pulisher
Oct 04, 2024

Summit Therapeutics Stock Jumps as Lung Cancer Drug Placed on FDA Fast Track - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Spirit Airlines, Palantir, Rivian, CVS, Albemarle, Apogee, and More Stock Movers - Barron's

Oct 04, 2024
pulisher
Oct 04, 2024

Summit Therapeutics Stock Jumps as Lung Cancer Drug Placed on FDA Fast Track - Yahoo Finance

Oct 04, 2024
pulisher
Oct 04, 2024

H.C. Wainwright keeps buy rating on Summit Therapeutics stock, highlighting Fast Track designation - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

Could Summit Therapeutics Become the Next Merck? - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Spirit Airlines, Palantir, Rivian, Maersk, Summit Therapeutics, CVS, and More Movers - Barron's

Oct 04, 2024
pulisher
Oct 04, 2024

Stocks making the biggest moves premarket: Spirit Airlines, Summit Therapeutics, Rivian and more - CNBC

Oct 04, 2024
pulisher
Oct 04, 2024

Could Summit Therapeutics Become the Next Merck? - Yahoo Finance

Oct 04, 2024
pulisher
Oct 04, 2024

S&P 500 Futures Rise in Premarket Trading; Summit Therapeutics, Axalta Coating Systems Lead - Barron's

Oct 04, 2024
pulisher
Oct 04, 2024

Summit completes subject enrolment in Phase III NSCLC treatment trial - Clinical Trials Arena

Oct 04, 2024
pulisher
Oct 04, 2024

Is Summit Therapeutics Inc. (SMMT) the Best High Short Interest Stock to Invest In Now? - Insider Monkey

Oct 04, 2024
pulisher
Oct 04, 2024

Is Summit Therapeutics Inc. (SMMT) the Best High Short Interest Stock to Invest In Now? - Yahoo Finance

Oct 04, 2024
pulisher
Oct 04, 2024

H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT) - StreetInsider.com

Oct 04, 2024
pulisher
Oct 04, 2024

Summit stock jumps as FDA grants fast track tag for lung cancer therapy - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Biggest stock movers Friday: SAVE and SMMT - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Summit stock jumps as FDA grants fast track tag for lung cancer therapy (NASDAQ:SMMT) - Seeking Alpha

Oct 04, 2024
pulisher
Oct 04, 2024

Biggest stock movers Friday: SAVE and SMMT - Seeking Alpha

Oct 04, 2024
pulisher
Oct 04, 2024

Summit completes subject enrolment in Phase III NSCLC treatment trial - Yahoo Finance

Oct 04, 2024
pulisher
Oct 03, 2024

Where Will Summit Therapeutics Be in 3 Years? - sharewise

Oct 03, 2024
pulisher
Oct 03, 2024

Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC - Business Wire

Oct 03, 2024
pulisher
Oct 03, 2024

Where Will Summit Therapeutics Be in 3 Years? - MSN

Oct 03, 2024
pulisher
Oct 03, 2024

Where Will Summit Therapeutics Be in 3 Years? - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

5 stocks that have been short-term winners so far this year - Financial Post

Oct 03, 2024
pulisher
Oct 02, 2024

Has Summit Therapeutics Stock Already Peaked? - AOL

Oct 02, 2024
pulisher
Oct 02, 2024

Has Summit Therapeutics Stock Already Peaked? - MSN

Oct 02, 2024
pulisher
Oct 02, 2024

Serina Therapeutics to Present at the 14th Annual Injectables Summit - Yahoo Finance

Oct 02, 2024
pulisher
Oct 02, 2024

Has Summit Therapeutics Stock Already Peaked? - Yahoo Finance

Oct 02, 2024
pulisher
Oct 01, 2024

Summit Therapeutics (NASDAQ:SMMT) Trading Down 7% - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Is Summit Therapeutics Stock a Buy? - MSN

Oct 01, 2024
pulisher
Oct 01, 2024

Foghorn Therapeutics to Participate in the BMO Oncology Summit - Yahoo Finance

Oct 01, 2024

Summit Therapeutics Inc Stock (SMMT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Summit Therapeutics Inc Stock (SMMT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Zanganeh Mahkam
Chief Executive Officer
Mar 26 '24
Buy
3.75
30,000
112,500
30,000
Zanganeh Mahkam
Chief Executive Officer
Mar 27 '24
Buy
3.72
26,000
96,720
520,814
Dhingra Ankur
Chief Financial Officer
Mar 26 '24
Buy
3.75
100,000
375,000
354,958
Zanganeh Mahkam
Chief Executive Officer
Dec 12 '23
Buy
2.07
5,000
10,350
494,814
Dhingra Ankur
Chief Financial Officer
Dec 13 '23
Buy
2.17
20,400
44,254
254,958
Soni Manmeet Singh
Chief Operating Officer
Oct 13 '23
Buy
1.68
2,976,190
4,999,999
2,976,190
$23.53
price down icon 0.76%
$358.22
price up icon 0.97%
$58.29
price up icon 2.64%
$236.05
price down icon 1.39%
$120.55
price up icon 1.71%
$536.70
price up icon 1.65%
Cap:     |  Volume (24h):